CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
511-525 of 1196
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
MinuteCE®Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
MinuteCE®Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
The Critical Interplay: CKD, HF, and HyperkaleAmia
MinuteCE®The Critical Interplay: CKD, HF, and HyperkaleAmia
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
MinuteCE®Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
- advertisement
Future Directions in Managing Hyperkalemia in CKD and HF
MinuteCE®Future Directions in Managing Hyperkalemia in CKD and HF
Current FSGS Treatment Landscape: More Questions Than Answers
MinuteCE®Current FSGS Treatment Landscape: More Questions Than Answers
DEARA Versus SOC in FSGS Management: Clinical Trial Insights
MinuteCE®DEARA Versus SOC in FSGS Management: Clinical Trial Insights
FSGS: Interpretation of Proteinuria Reduction Thresholds
MinuteCE®FSGS: Interpretation of Proteinuria Reduction Thresholds
Integrating the Patient Voice in FSGS Management
MinuteCE®Integrating the Patient Voice in FSGS Management
Emerging Therapies in Managing Adult and Pediatric Patients With FSGS: Latest Data
MinuteCE®Emerging Therapies in Managing Adult and Pediatric Patients With FSGS: Latest Data
- advertisement
Treatment Considerations for Pediatric Patients With FSGS
MinuteCE®Treatment Considerations for Pediatric Patients With FSGS
Bronchiectasis Update: Diagnostic Innovations and Therapeutic Frontiers
CME/CEBronchiectasis Update: Diagnostic Innovations and Therapeutic Frontiers

















































